Endothelial cells and human cerebral small vessel disease

Brain Pathology

Volumn 25, Issue 1, 2015, Pages 44-50

  Hainsworth, Atticus H ^a   Oommen, Asho T ^a   Bridges, Leslie R ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

endothelial cells; human subcortical small vessel disease; vascular dementia

Indexed keywords

GADOLINIUM; PLASMA PROTEIN;

ANTIBODY LABELING; ARTERIOLOSCLEROSIS; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CELL; BRAIN TISSUE; CELL ACTIVATION; CELL FUNCTION; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRAVASATION; HUMAN; HUMAN CELL; LEUKOARAIOSIS; MUSCLE ATROPHY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER LESION; BRAIN; BRAIN CIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 84923370285     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12224     Document Type: Conference Paper

References (104)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ, (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25.
2. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H, (1998) Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol 95: 78-84.
3. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B, (1985) Perivascular deposits of serum proteins in cerebral cortex in vascular dementia. Acta Neuropathol 66: 292-298.
4. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR, (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 106: 1977-1982.
5. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al (2006) IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-Angiogenesis program. J Immunol 177: 5574-5584.
6. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA, (2010) Glial and neuronal control of brain blood flow. Nature 468: 232-243.
7. Baker AB, (1941) Structure of the small cerebral arteries in hypertension. Am J Pathol 17: 39-46.
8. Baumbach GL, Heistad DD, (1988) Cerebral circulation in chronic arterial hypertension. Hypertension 12: 89-95.
9. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV, (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
10. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516.
11. Bevan S, Markus HS, (2013) Genetic profiles in ischaemic stroke. Curr Atheroscler Rep 15: 342.
12. Bridges LR, Andoh J, Lawrence AJ, Khoong CH, Poon WW, Esir MM, Markus HS, Hainsworth AH, (2014) Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol 73: 1026-1033.
13. Craggs LJ, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Andersen O, Viitanen M, et al (2013) Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases. Brain Pathol 23: 547-557.
14. de Leeuw FE, de Kleine M, Frijns CJ, Fijnheer R, van Gijn J, Kappelle LJ, (2002) Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann N Y Acad Sci 977: 306-314.
15. del Zoppo GJ, Milner R, (2006) Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 26: 1966-1975.
16. Deplanque D, Lavallee PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, et al (2013) Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study. Int J Stroke 8: 413-421.
17. Dozono K, Ishii N, Nishihara Y, Horie A, (1991) An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke 22: 993-996.
18. Enerson BE, Drewes LR, (2006) The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26: 959-973.
19. Esiri MM, Wilcock GK, Morris JH, (1997) Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63: 749-753.
20. Farrall AJ, Wardlaw JM, (2009) Blood-brain barrier: ageing and microvascular disease-systematic review and meta-Analysis. Neurobiol Aging 30: 337-352.
21. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M, (1999) Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 30: 1647-1650.
22. Feigin I, Popoff N, (1963) Neuropathological changes late in cerebral edema: the relationship to trauma, hypertensive disease and Binswanger's encephalopathy. J Neuropathol Exp Neurol 22: 500-511.
23. Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, et al (2004) Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30: 385-395.
24. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al (2006) White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37: 1391-1398.
25. Fisher CM, (1968) The arterial lesions underlying lacunes. Acta Neuropathol 12: 1-15.
26. Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, Siscovick DS, et al (2008) Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study. Stroke 39: 1952-1959.
27. Frischer JM, Pipp I, Stavrou I, Trattnig S, Hainfellner JA, Knosp E, (2008) Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition. J Neurol Neurosurg Psychiatry 79: 783-788.
28. Gallin JI, Snyderman R, (1999) Inflammation: Basic Principles and Clinical Correlates, 3rd edn. Lippincott Williams & Wilkins: Philadelphia.
29. Giwa MO, Williams J, Elderfield K, Jiwa NS, Bridges LR, Kalaria RN, et al (2012) Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 78: 167-174.
30. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 2672-2713.
31. Gormley K, Bevan S, Hassan A, Markus HS, (2005) Polymorphisms in genes of the endothelin system and cerebral small-vessel disease. Stroke 36: 1656-1660.
32. Goveia J, Stapor P, Carmeliet P, (2014) Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med 6: 1105-1120.
33. Gunarathne A, Patel JV, Kausar S, Gammon B, Hughes EA, Lip GY, (2009) Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project. Stroke 40: 2298-2306.
34. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37: 2220-2241.
35. Han JH, Wong KS, Wang YY, Fu JH, Ding D, Hong Z, (2009) Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects. Clin Neurol Neurosurg 111: 847-851.
36. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, et al (2004) Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35: 654-659.
37. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, et al (2003) Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126: 424-432.
38. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, et al (2004) Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127: 212-219.
39. Hegt VN, (1976) Distribution and variation of fibrinolytic activity in the walls of human arteries and veins. Haemostasis 5: 355-372.
40. Hooper WC, Catravas JD, Heistad DD, Sessa WC, Mensah GA, (2007) Vascular endothelium summary statement I: health promotion and chronic disease prevention. Vascul Pharmacol 46: 315-317.
41. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Fontana V, Ahn YS, (2008) Transendothelial migration of leukocytes is promoted by plasma from a subgroup of immune thrombocytopenic purpura patients with small-vessel ischemic brain disease. Am J Hematol 83: 206-211.
42. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R, (1999) Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 30: 1396-1401.
43. Khan U, Hassan A, Vallance P, Markus HS, (2007) Asymmetric dimethylarginine in cerebral small vessel disease. Stroke 38: 411-413.
44. Kilarski LL, Achterberg S, Devan WJ, Traylor M, Malik R, Lindgren A, et al (2014) Meta-Analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology 83: 678-685.
45. Kimura A, Sakurai T, Yamada M, Koumura A, Hayashi Y, Tanaka Y, et al (2012) Anti-endothelial cell antibodies in patients with cerebral small vessel disease. Curr Neurovasc Res 9: 296-301.
46. Knottnerus IL, Govers-Riemslag JW, Hamulyak K, Rouhl RP, Staals J, Spronk HM, et al (2010) Endothelial activation in lacunar stroke subtypes. Stroke 41: 1617-1622.
47. Knottnerus IL, ten Cate H, Lodder J, Kessels F, van Oostenbrugge RJ, (2009) Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis 27: 519-526.
48. Lammie GA, (2000) Pathology of small vessel stroke. Br Med Bull 56: 296-306.
49. Lammie GA, (2002) Hypertensive cerebral small vessel disease and stroke. Brain Pathol 12: 358-370.
50. Lammie GA, (2005) Small vessel disease. In: Cerebrovascular Disease: Pathology and Genetics., H Kalimo, (ed.), pp. 85-91. ISN Neuropathology Press: Basle.
51. Lammie GA, Brannan F, Slattery J, Warlow C, (1997) Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 28: 2222-2229.
52. Lavallee PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, Klein IF, et al (2009) Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke 40: 1721-1728.
53. Lavallee PC, Labreuche J, Faille D, Huisse MG, Nicaise-Roland P, Dehoux M, et al (2013) Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease. Cerebrovasc Dis 36: 131-138.
54. Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, et al (2011) Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell 20: 291-302.
55. Ma KC, Olsson Y, (1993) Structural and vascular permeability abnormalities associated with lacunes of the human brain. Acta Neurol Scand 88: 100-107.
56. Marcelo KL, Goldie LC, Hirschi KK, (2013) Regulation of endothelial cell differentiation and specification. Circ Res 112: 1272-1287.
57. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC, (2000) Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 69: 48-53.
58. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, Schmidt R, (2005) Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke 36: 1410-1414.
59. Markus HS, Allan CL, Ebmeier KP, (2014) Cerebral hemodynamics in cerebral small vessel disease. In: Cerebral Small Vessel Disease., L Pantoni, PB Gorelick, (eds), pp. 180-191. Cambridge University Press: Cambridge.
60. Martens RJ, Vink H, van Oostenbrugge RJ, Staals J, (2013) Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovasc Dis 35: 451-454.
61. Masawa N, Yoshida Y, Yamada T, Joshita T, Sato S, Mihara B, (1994) Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 25: 122-127.
62. Meng H, Zhang X, Lee SJ, Wang MM, (2013) Von Willebrand factor inhibits mature smooth muscle gene expression through impairment of Notch signaling. PLoS ONE 8: e75808.
63. Miao Q, Paloneva T, Tuominen S, Poyhonen M, Tuisku S, Viitanen M, Kalimo H, (2004) Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol 14: 358-364.
64. Miao Q, Paloneva T, Tuisku S, Roine S, Poyhonen M, Viitanen M, Kalimo H, (2006) Arterioles of the lenticular nucleus in CADASIL. Stroke 37: 2242-2247.
65. Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, et al (2014) Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137: 255-267.
66. Ohtsuki S, Hirayama M, Ito S, Uchida Y, Tachikawa M, Terasaki T, (2014) Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics. Expert Rev Proteomics 11: 303-313.
67. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, Markus HS, (2002) Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59: 321-326.
68. Pantoni L, (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9: 689-701.
69. Pardridge WM, (2005) Molecular biology of the blood-brain barrier. Mol Biotechnol 30: 57-70.
70. Perry VH, Holmes C, (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10: 217-224.
71. Peters N, Freilinger T, Opherk C, Pfefferkorn T, Dichgans M, (2007) Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL. J Neurol Sci 260: 100-105.
72. Peters N, Freilinger T, Opherk C, Pfefferkorn T, Dichgans M, (2008) Enhanced L-Arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL. J Neurol 255: 1203-1208.
73. Rouhl RP, van Oostenbrugge RJ, Damoiseaux JG, Brus-Palmans LL, Theunissen RO, Knottnerus IL, et al (2009) Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res 6: 32-41.
74. Rouhl RP, van Oostenbrugge RJ, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, et al (2010) Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease. Stroke 41: 2687-2689.
75. Rouhl RP, Damoiseaux JG, Lodder J, Theunissen RO, Knottnerus IL, Staals J, et al (2012) Vascular inflammation in cerebral small vessel disease. Neurobiol Aging 33: 1800-1806.
76. Rouhl RP, Mertens AE, van Oostenbrugge RJ, Damoiseaux JG, Brus-Palmans LL, Henskens LH, et al (2012) Angiogenic T-cells and putative endothelial progenitor cells in hypertension-related cerebral small vessel disease. Stroke 43: 256-258.
77. Ruchoux MM, Brulin P, Leteurtre E, Maurage CA, (2000) Skin biopsy value and leukoaraiosis. Ann N Y Acad Sci 903: 285-292.
78. Rufa A, Blardi P, De Lalla A, Cevenini G, De SN, Zicari E, et al (2008) Plasma levels of asymmetric dimethylarginine in cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy. Cerebrovasc Dis 26: 636-640.
79. Salter MW, Beggs S, (2014) Sublime microglia: expanding roles for the guardians of the CNS. Cell 158: 15-24.
80. Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, et al (2011) Heterogeneity in age-related white matter changes. Acta Neuropathol 122: 171-185.
81. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV, (2013) Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 23: 303-310.
82. Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, Esiri M, (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38: 337-343.
83. Staals J, Henskens LH, Delanghe JR, van Oostenbrugge RJ, Kessels AG, Kroon AA, et al (2010) Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res 7: 1-5.
84. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM, (2010) A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 41: e434-e442.
85. Streit WJ, Xue QS, (2014) Human CNS immune senescence and neurodegeneration. Curr Opin Immunol 29C: 93-96.
86. Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, et al (2011) Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42: 2158-2163.
87. Thompson CS, Hakim AM, (2009) Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 40: e322-e330.
88. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, Kimura J, (1996) Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 27: 2069-2074.
89. Topakian R, Barrick TR, Howe FA, Markus HS, (2010) Blood-brain barrier permeability is increased in normal-Appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 81: 192-197.
90. Umemura T, Kawamura T, Umegaki H, Mashita S, Kanai A, Sakakibara T, et al (2011) Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 82: 1186-1194.
91. Utter S, Tamboli IY, Walter J, Upadhaya AR, Birkenmeier G, Pietrzik CU, et al (2008) Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J Neuropathol Exp Neurol 67: 842-856.
92. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, et al (2010) White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75: 160-167.
93. Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, et al (2011) Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci Lett 505: 25-30.
94. Wada M, Nagasawa H, Iseki C, Takahashi Y, Sato H, Arawaka S, et al (2008) Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 272: 36-42.
95. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, et al (2007) Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 255: 27-34.
96. Wada M, Takahashi Y, Iseki C, Kawanami T, Daimon M, Kato T, (2011) Plasma fibrinogen, global cognitive function, and cerebral small vessel disease: results of a cross-sectional study in community-dwelling Japanese elderly. Intern Med 50: 999-1007.
97. Wardlaw JM, Sandercock PA, Dennis MS, Starr J, (2003) Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34: 806-812.
98. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz MS, et al (2009) Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 65: 194-202.
99. Wardlaw JM, Doubal FN, Valdes-Hernandez M, Wang X, Chappell FM, Shuler K, et al (2013) Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke 44: 525-527.
100. Young VG, Halliday GM, Kril JJ, (2008) Neuropathologic correlates of white matter hyperintensities. Neurology 71: 804-811.
101. Zhang WW, Olsson Y, (1997) The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol 93: 219-224.
102. Zhang WW, Lempessi H, Olsson Y, (1998) Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol 96: 558-563.
103. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
104. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nabavi DG, Edelmann M, Ringelstein EB, (1996) Hyperinsulinism and cerebral microangiopathy. Stroke 27: 219-223.